IPH LIMITED (IPH)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IPH - IPH LIMITED

FNArena Sector : Legal
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.55
Index: ASX200 | ASX300 | ALL-ORDS

IPH Ltd is Australia's largest intellectual property services company providing protection, commercialisation and management of intellectual property. It has been a listed company since 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.97

13 Sep
2024

-0.080

OPEN

$6.08

-1.32%

HIGH

$6.08

450,621

LOW

$5.95

TARGET
$7.965

-0.22 change from previous day

33.4% upside
Franking for last dividend paid out: 35%
OTHER COMPANIES IN THE SAME SECTOR
SHJ .
FNARENA'S MARKET CONSENSUS FORECASTS
IPH: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 25.1 46.8 xxx
DPS (cps) xxx 35.0 36.4 xxx
EPS Growth xxx - 12.4% 86.7% xxx
DPS Growth xxx 6.1% 3.9% xxx
PE Ratio xxx N/A 12.7 xxx
Dividend Yield xxx N/A 6.1% xxx
Div Pay Ratio(%) xxx 139.6% 77.7% xxx

Dividend yield today if purchased 3 years ago: 3.74%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

5.86

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/02 - ex-div 16c (franking 35%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx25.1
DPS All xxxxxxxxxxxxxxx35.0
Sales/Revenue xxxxxxxxxxxxxxx605.6 M
Book Value Per Share xxxxxxxxxxxxxxx257.4
Net Operating Cash Flow xxxxxxxxxxxxxxx131.9 M
Net Profit Margin xxxxxxxxxxxxxxx10.04 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx10.04 %
Return on Invested Capital xxxxxxxxxxxxxxx5.72 %
Return on Assets xxxxxxxxxxxxxxx4.84 %
Return on Equity xxxxxxxxxxxxxxx10.04 %
Return on Total Capital xxxxxxxxxxxxxxx11.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx64.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx10 M
Long Term Debt xxxxxxxxxxxxxxx482 M
Total Debt xxxxxxxxxxxxxxx492 M
Goodwill - Gross xxxxxxxxxxxxxxx594 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx76 M
Price To Book Value xxxxxxxxxxxxxxx2.44

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx11.0 M
Capex % of Sales xxxxxxxxxxxxxxx1.82 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx413 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

23/08/2024

1

Buy

$8.00

34.00%

IPH delivered a "solid" result with the top line better than expected, UBS asserts. Australasia and Canada were "surprisingly strong". Asian growth expectations have been pushed out and IPH Way cost cutting benefits are to be spread across FY25 and FY26.

The net impact is a reduction in the broker's EBITDA forecast by -3%. UBS is encouraged by the improvement in top-line momentum and retains a Buy rating. Target is $8.

IPH will acquire Canadian IP firm Bereskin & Parr for -$90m, taking its total Canadian share to almost 35%.

FORECAST
UBS forecasts a full year FY25 EPS of 46.00 cents.
UBS forecasts a full year FY26 EPS of 49.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

4

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Petra Capital

31/07/2024

1

Buy

$8.20

37.35%

Petra Capital reviews patent filings for the June half and finds IPH Ltd is falling behind market, the company posting relatively weak filings in the month of June vs the previous June.

The broker observes IPH has retained market share of 32% on a full-year view.

All up, Petra Capital determines while the company's Australian filings eased year-on-year, it suspects the inclusion of transferred cases could see the balance shift to the black.

Buy rating retained. Target price falls to $8.20 from $10.50.

FORECAST
Petra Capital forecasts a full year FY25 dividend of 35.90 cents and EPS of 47.40 cents.

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

IPH STOCK CHART